Adjunct Associate Professor, Microbiology & Immunology and Neuroscience — Cell Biology
Murine leukemia viruses; gene therapy;
|PhD | 1993 | University Adelaide, Australia|
|BSc | 1988 | University of Adelaide, Australia|
Overview: Murine Leukemia Viruses, Gene Therapy, Viral entry.
Robert Davey joined UTMB in 2000, coming from Harvard Medical School in Boston, where he was an instructor in medicine. Presently, he is an Associate Professor in the Department of Microbiology and Immunology and a member of the Galveston National Laboratory as well as the Institute of Human Infection and Immunity. His work has been focused on identification of cellular factors important for establishing infection by retroviruses and more recently, filoviruses. He is trained to work at BSL4 and operates a multidiscipline laboratory applying modern molecular techniques to these little studied pathogens. This has culminated in a deeper understanding of the entry and cell signaling pathways that are used by viruses to penetrate the cell membrane and establish infection. His work as been published in Nature and Science and more recently, work with the BSL4 agent, Ebolavirus, has been published in the high-impact journal PLoS pathogens. Other work of note is his study in 2009, on the use of siRNA to identify host factors important for Ebolavirus infection and drug discovery, which appeared in Drug Development Research and has been cited in the popular literature. His current work has expanded into other BSL4 pathogens including, but not limited to, the arenaviruses (Junin and Lassa fever virus) as well as bunyaviruses and aims to identify new therapeutics for these pathogens.